Article
Sarcopenia and immune-mediated inflammatory diseases: Evaluating causality and exploring therapeutic targets for sarcopenia through Mendelian randomization.
International immunopharmacology - 10 Jan 2025
Wang Qijun, Zhao Xuan, Wang Shuaikang, Lu Shibao
Abstract excerpt
BACKGROUND: An increasing body of evidence has revealed the association between immune-mediated inflammatory diseases (IMIDs) and sarcopenia. However, a genetically direct causality between IMIDs and sarcopenia remains elusive. METHODS: To investigate the relationship between IMIDs and sarcopenia-related traits and identify potential therapeutic targets, a Mendelian randomization (MR) was performed. We collected...
Topics
Join the communities discussing this publication.
